

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Corallopyronin A
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : The Global Health Innovative Technology
Deal Size : $5.9 million
Deal Type : Funding
USD 10.8 Mn Invested in New Drug Development for Malaria with Japanese Pharma Partners
Details : The net proceeds will be used for the preclinical development of the macrofilaricide corallopyronin A (CorA) for the treatment of onchocerciasis and lymphatic filariasis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
May 08, 2024
Lead Product(s) : Corallopyronin A
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : The Global Health Innovative Technology
Deal Size : $5.9 million
Deal Type : Funding
